Bio-Labs recently developed Colinext (colistimethate) 1MIU in fulfilling the needs of emerging molecules in the market. It is used in the infections caused by gram negative bacteria’s which are highly resistant to conventional therapies.
Research
for
better
HealthCopyrights © - 2024 Bio-Labs | All rights reserved.
